Specialty pharmaceutical company Columbia Laboratories (CBRX -41%) gets clobbered today after...
Specialty pharmaceutical company Columbia Laboratories (CBRX -41%) gets clobbered today after the FDA denies Watson Pharmaceuticals (WPI -0.5%) formal dispute-resolution request related to its new-drug application for Prochieve, a treatment for the prevention of preterm birth. Watson said it intends to review possible options to continue pursuit of the the drug's development.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs